Michael Grisanti
Rheumatology · Orchard Park, NYNPI 1851326177
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $26,000 of the $31,946 with a category attached, or 81.4%. Mallinckrodt Enterprises LLC accounts for 75.3% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $26,532 and has fallen 99.1% since, to $246 in 2024.
Across 240 payments — averaging $133.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Enterprises LLC$24K
- Mallinckrodt Hospital Products Inc.$5K
- AbbVie$435
- Amgen$408
- Johnson & Johnson$388
- Novartis$355
- plus $2K from 18 others
Across 11 payments — averaging $1273.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$13K
- Sandoz$1K
What the payments were for
- Consulting fees$1,7005%
- Speaking & faculty fees$26,00081%
- Food & beverage$4,14713%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Enterprises LLC | 19 | $24,046 |
| Mallinckrodt Hospital Products Inc. | 6 | $4,777 |
| AbbVie | 27 | $435 |
| Amgen(2 entities) | 23 | $408 |
| Johnson & Johnson | 36 | $388 |
| Novartis | 20 | $355 |
| Genentech USA, Inc. | 14 | $279 |
| Pfizer | 34 | $253 |
| Sanofi | 11 | $194 |
| Bristol Myers Squibb | 8 | $141 |
| GSK | 8 | $130 |
| E.r. Squibb & Sons, L.L.C. | 8 | $114 |
| UCB, Inc. | 5 | $95 |
| Radius Health, Inc. | 5 | $76 |
| Sanofi-aventis U.S. LLC | 3 | $37 |
| Lilly USA, LLC | 2 | $34 |
| Sobi, Inc | 2 | $34 |
| Merck | 2 | $32 |
| Actelion Pharmaceuticals US, Inc. | 2 | $28 |
| Sanofi Pasteur Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $22 |
| Gilead | 1 | $18 |
| Grifols USA, LLC | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTHAR$28,654
How this compares
$31,946 in reported general payments places this provider in the 85th percentile of 541 rheumatology providers in New York.
Other rheumatology in Orchard Park
- Laurie GlimcherNew York$3.9M
- Grace WrightNew York$3M
- Kostas BotsoglouCheektowaga$2.6M
- Sergio SchwartzmanNew York$2.5M
- Allan GibofskyNew York$1.9M
- Petros EfthimiouNew York$791K
- Richard FurieNew Hyde Park$746K
- Barry GruberBabylon$742K
- Olga PetrynaNew York$509K
- Sanjay GodhwaniWading River$472K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.